Clinical Trial Update: Effects of Doravirine (MK-1439) on Methadone Pharmacokinetics in Methadone-Maintained Participants (MK-1439-045) [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating how doravirine (MK-1439) affects the pharmacokinetics of methadone in individuals maintained on methadone for HIV treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Doravirine (doravirine)
• Methadone (methadone)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Human Immunodeficiency Virus (HIV) Infection | Phase 1 | Status: COMPLETED | Results posted: 2019-06-03